| Trial ID: |  L0891 | 
                      | Source ID: |  NCT02283710
                       | 
                      | Associated Drug: | 
                        
                          Pentoxifylline
                        
                       | 
                      | Title: | 
                        
                          The Effect of Pentoxifylline on Liver Function Tests in Non-alcoholic Fatty Liver Disease Patients Refereed to Sina Hospital Gastroenterology Clinic
                        
                       | 
                      | Acronym: | 
                        
                        --
                        
                       | 
                      | Status: | 
                        
                          Not recruiting
                        
                       | 
                      | Study Results: | 
                        
                          No Results Available
                        
                       | 
                      | Results: | 
                        
                        --
                        
                       | 
                      | Conditions: | 
                        
                        Fatty Liver
                        
                       | 
                      | Interventions: | 
                      
                          Drug: Pentoxifylline;Behavioral: Lifestyle modification
                        
                       | 
                      | Outcome Measures: | 
                      
                          Change from baseline serum alanine aminotransferase at 6 monthsChange from baseline serum aspartate aminotransferase at 6 months
                        
                       | 
                      | Sponsor/Collaborators: | 
                      
                          Tehran University of Medical Sciences
                        
                       | 
                      | Gender: | 
                      
                          All
                        
                       | 
                      | Age: | 
                      
                          18 Yearsnan
                        
                       | 
                      | Phases: | 
                      
                          Phase 2
                        
                       | 
                      | Enrollment: | 
                      
                          120
                        
                       | 
                      | Study Type: | 
                      
                          Interventional
                        
                       | 
                      | Study Designs: | 
                      
                          Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Caregiver, Outcomes Assessor), Primary Purpose: Treatment
                        
                       | 
                      | Start Date: | 
                      
                          01/11/2014
                        
                       | 
                      | Completion Date: | 
                      
                        --
                        
                       | 
                      | Results First Posted: | 
                      
                        --
                        
                       | 
                      | Last Update Posted: | 
                      
                          19 February 2015
                        
                       | 
                      | Locations: | 
                      
                          Iran, Islamic Republic of
                        
                       | 
                      | URL: | 
                      
                          http://clinicaltrials.gov/show/NCT02283710
                        
                       |